USA Oral Contrast Agent Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Oral Contrast Agent market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Oral Contrast Agent market. Detailed analysis of key players, along with key growth strategies adopted by Oral Contrast Agent industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Bracco Imaging (Italy)

    • Daiichi Sankyo (Japan)

    • Bayer HealthCare (Germany)

    • GE Healthcare (US)

    • Jodas (India)

    • Unijules Life Sciences (India)

    • Taejoon Pharm (South Korea)

    • Lantheus (US)

    • Spago Nanomedicine (Sweden)

    • JB Chemicals and Pharmaceuticals (India)

    • Magnus Health (India)

    • Guerbet (France)

    By Type:

    • Barium-based Contrast Media

    • Iodinated Contrast Media

    • Gadolinium-based Contrast Media

    • Microbubble Contrast Media

    By End-User:

    • Cardiovascular Disorders

    • Cancer

    • Gastrointestinal Disorders

    • Musculoskeletal Disorders

    • Neurological Disorders

    • Nephrological Disorders

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oral Contrast Agent Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Oral Contrast Agent Market Size and Growth Rate of Barium-based Contrast Media from 2016 to 2027

      • 1.3.2 USA Oral Contrast Agent Market Size and Growth Rate of Iodinated Contrast Media from 2016 to 2027

      • 1.3.3 USA Oral Contrast Agent Market Size and Growth Rate of Gadolinium-based Contrast Media from 2016 to 2027

      • 1.3.4 USA Oral Contrast Agent Market Size and Growth Rate of Microbubble Contrast Media from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Oral Contrast Agent Market Size and Growth Rate of Cardiovascular Disorders from 2016 to 2027

      • 1.4.2 USA Oral Contrast Agent Market Size and Growth Rate of Cancer from 2016 to 2027

      • 1.4.3 USA Oral Contrast Agent Market Size and Growth Rate of Gastrointestinal Disorders from 2016 to 2027

      • 1.4.4 USA Oral Contrast Agent Market Size and Growth Rate of Musculoskeletal Disorders from 2016 to 2027

      • 1.4.5 USA Oral Contrast Agent Market Size and Growth Rate of Neurological Disorders from 2016 to 2027

      • 1.4.6 USA Oral Contrast Agent Market Size and Growth Rate of Nephrological Disorders from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Oral Contrast Agent Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Oral Contrast Agent Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Oral Contrast Agent Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Oral Contrast Agent Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Oral Contrast Agent Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oral Contrast Agent by Major Types

      • 3.4.1 Market Size and Growth Rate of Barium-based Contrast Media

      • 3.4.2 Market Size and Growth Rate of Iodinated Contrast Media

      • 3.4.3 Market Size and Growth Rate of Gadolinium-based Contrast Media

      • 3.4.4 Market Size and Growth Rate of Microbubble Contrast Media

    4 Segmentation of Oral Contrast Agent Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oral Contrast Agent by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oral Contrast Agent in Cardiovascular Disorders

      • 4.4.2 Market Size and Growth Rate of Oral Contrast Agent in Cancer

      • 4.4.3 Market Size and Growth Rate of Oral Contrast Agent in Gastrointestinal Disorders

      • 4.4.4 Market Size and Growth Rate of Oral Contrast Agent in Musculoskeletal Disorders

      • 4.4.5 Market Size and Growth Rate of Oral Contrast Agent in Neurological Disorders

      • 4.4.6 Market Size and Growth Rate of Oral Contrast Agent in Nephrological Disorders

    5 Market Analysis by Regions

    • 5.1 USA Oral Contrast Agent Production Analysis by Regions

    • 5.2 USA Oral Contrast Agent Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Oral Contrast Agent Landscape Analysis

    • 6.1 West USA Oral Contrast Agent Landscape Analysis by Major Types

    • 6.2 West USA Oral Contrast Agent Landscape Analysis by Major End-Users

    7 South USA Oral Contrast Agent Landscape Analysis

    • 7.1 South USA Oral Contrast Agent Landscape Analysis by Major Types

    • 7.2 South USA Oral Contrast Agent Landscape Analysis by Major End-Users

    8 Middle West USA Oral Contrast Agent Landscape Analysis

    • 8.1 Middle West USA Oral Contrast Agent Landscape Analysis by Major Types

    • 8.2 Middle West USA Oral Contrast Agent Landscape Analysis by Major End-Users

    9 Northeast USA Oral Contrast Agent Landscape Analysis

    • 9.1 Northeast USA Oral Contrast Agent Landscape Analysis by Major Types

    • 9.2 Northeast USA Oral Contrast Agent Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Bracco Imaging (Italy)

        • 10.1.1 Bracco Imaging (Italy) Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Daiichi Sankyo (Japan)

        • 10.2.1 Daiichi Sankyo (Japan) Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Bayer HealthCare (Germany)

        • 10.3.1 Bayer HealthCare (Germany) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 GE Healthcare (US)

        • 10.4.1 GE Healthcare (US) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Jodas (India)

        • 10.5.1 Jodas (India) Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Unijules Life Sciences (India)

        • 10.6.1 Unijules Life Sciences (India) Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Taejoon Pharm (South Korea)

        • 10.7.1 Taejoon Pharm (South Korea) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Lantheus (US)

        • 10.8.1 Lantheus (US) Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Spago Nanomedicine (Sweden)

        • 10.9.1 Spago Nanomedicine (Sweden) Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 JB Chemicals and Pharmaceuticals (India)

        • 10.10.1 JB Chemicals and Pharmaceuticals (India) Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Magnus Health (India)

        • 10.11.1 Magnus Health (India) Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Guerbet (France)

        • 10.12.1 Guerbet (France) Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Barium-based Contrast Media from 2016 to 2027

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Iodinated Contrast Media from 2016 to 2027

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Gadolinium-based Contrast Media from 2016 to 2027

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Microbubble Contrast Media from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Cardiovascular Disorders from 2016 to 2027

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Cancer from 2016 to 2027

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Gastrointestinal Disorders from 2016 to 2027

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Musculoskeletal Disorders from 2016 to 2027

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Neurological Disorders from 2016 to 2027

    • Figure USA Oral Contrast Agent Market Size and Growth Rate of Nephrological Disorders from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Oral Contrast Agent Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Oral Contrast Agent Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Oral Contrast Agent Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Oral Contrast Agent Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Oral Contrast Agent Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Oral Contrast Agent

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oral Contrast Agent by Different Types from 2016 to 2027

    • Table Consumption Share of Oral Contrast Agent by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Barium-based Contrast Media

    • Figure Market Size and Growth Rate of Iodinated Contrast Media

    • Figure Market Size and Growth Rate of Gadolinium-based Contrast Media

    • Figure Market Size and Growth Rate of Microbubble Contrast Media

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Oral Contrast Agent by Different End-Users from 2016 to 2027

    • Table Consumption Share of Oral Contrast Agent by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Cardiovascular Disorders

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Gastrointestinal Disorders

    • Figure Market Size and Growth Rate of Musculoskeletal Disorders

    • Figure Market Size and Growth Rate of Neurological Disorders

    • Figure Market Size and Growth Rate of Nephrological Disorders

    • Table USA Oral Contrast Agent Production by Regions

    • Table USA Oral Contrast Agent Production Share by Regions

    • Figure USA Oral Contrast Agent Production Share by Regions in 2016

    • Figure USA Oral Contrast Agent Production Share by Regions in 2021

    • Figure USA Oral Contrast Agent Production Share by Regions in 2027

    • Table USA Oral Contrast Agent Consumption by Regions

    • Table USA Oral Contrast Agent Consumption Share by Regions

    • Figure USA Oral Contrast Agent Consumption Share by Regions in 2016

    • Figure USA Oral Contrast Agent Consumption Share by Regions in 2021

    • Figure USA Oral Contrast Agent Consumption Share by Regions in 2027

    • Table West USA Oral Contrast Agent Consumption by Types from 2016 to 2027

    • Table West USA Oral Contrast Agent Consumption Share by Types from 2016 to 2027

    • Figure West USA Oral Contrast Agent Consumption Share by Types in 2016

    • Figure West USA Oral Contrast Agent Consumption Share by Types in 2021

    • Figure West USA Oral Contrast Agent Consumption Share by Types in 2027

    • Table West USA Oral Contrast Agent Consumption by End-Users from 2016 to 2027

    • Table West USA Oral Contrast Agent Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Oral Contrast Agent Consumption Share by End-Users in 2016

    • Figure West USA Oral Contrast Agent Consumption Share by End-Users in 2021

    • Figure West USA Oral Contrast Agent Consumption Share by End-Users in 2027

    • Table South USA Oral Contrast Agent Consumption by Types from 2016 to 2027

    • Table South USA Oral Contrast Agent Consumption Share by Types from 2016 to 2027

    • Figure South USA Oral Contrast Agent Consumption Share by Types in 2016

    • Figure South USA Oral Contrast Agent Consumption Share by Types in 2021

    • Figure South USA Oral Contrast Agent Consumption Share by Types in 2027

    • Table South USA Oral Contrast Agent Consumption by End-Users from 2016 to 2027

    • Table South USA Oral Contrast Agent Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Oral Contrast Agent Consumption Share by End-Users in 2016

    • Figure South USA Oral Contrast Agent Consumption Share by End-Users in 2021

    • Figure South USA Oral Contrast Agent Consumption Share by End-Users in 2027

    • Table Middle West USA Oral Contrast Agent Consumption by Types from 2016 to 2027

    • Table Middle West USA Oral Contrast Agent Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Oral Contrast Agent Consumption Share by Types in 2016

    • Figure Middle West USA Oral Contrast Agent Consumption Share by Types in 2021

    • Figure Middle West USA Oral Contrast Agent Consumption Share by Types in 2027

    • Table Middle West USA Oral Contrast Agent Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Oral Contrast Agent Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Oral Contrast Agent Consumption Share by End-Users in 2016

    • Figure Middle West USA Oral Contrast Agent Consumption Share by End-Users in 2021

    • Figure Middle West USA Oral Contrast Agent Consumption Share by End-Users in 2027

    • Table Northeast USA Oral Contrast Agent Consumption by Types from 2016 to 2027

    • Table Northeast USA Oral Contrast Agent Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Oral Contrast Agent Consumption Share by Types in 2016

    • Figure Northeast USA Oral Contrast Agent Consumption Share by Types in 2021

    • Figure Northeast USA Oral Contrast Agent Consumption Share by Types in 2027

    • Table Northeast USA Oral Contrast Agent Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Oral Contrast Agent Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Oral Contrast Agent Consumption Share by End-Users in 2016

    • Figure Northeast USA Oral Contrast Agent Consumption Share by End-Users in 2021

    • Figure Northeast USA Oral Contrast Agent Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Bracco Imaging (Italy)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging (Italy)

    • Figure Sales and Growth Rate Analysis of Bracco Imaging (Italy)

    • Figure Revenue and Market Share Analysis of Bracco Imaging (Italy)

    • Table Product and Service Introduction of Bracco Imaging (Italy)

    • Table Company Profile and Development Status of Daiichi Sankyo (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo (Japan)

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo (Japan)

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo (Japan)

    • Table Product and Service Introduction of Daiichi Sankyo (Japan)

    • Table Company Profile and Development Status of Bayer HealthCare (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer HealthCare (Germany)

    • Figure Sales and Growth Rate Analysis of Bayer HealthCare (Germany)

    • Figure Revenue and Market Share Analysis of Bayer HealthCare (Germany)

    • Table Product and Service Introduction of Bayer HealthCare (Germany)

    • Table Company Profile and Development Status of GE Healthcare (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare (US)

    • Figure Sales and Growth Rate Analysis of GE Healthcare (US)

    • Figure Revenue and Market Share Analysis of GE Healthcare (US)

    • Table Product and Service Introduction of GE Healthcare (US)

    • Table Company Profile and Development Status of Jodas (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jodas (India)

    • Figure Sales and Growth Rate Analysis of Jodas (India)

    • Figure Revenue and Market Share Analysis of Jodas (India)

    • Table Product and Service Introduction of Jodas (India)

    • Table Company Profile and Development Status of Unijules Life Sciences (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unijules Life Sciences (India)

    • Figure Sales and Growth Rate Analysis of Unijules Life Sciences (India)

    • Figure Revenue and Market Share Analysis of Unijules Life Sciences (India)

    • Table Product and Service Introduction of Unijules Life Sciences (India)

    • Table Company Profile and Development Status of Taejoon Pharm (South Korea)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taejoon Pharm (South Korea)

    • Figure Sales and Growth Rate Analysis of Taejoon Pharm (South Korea)

    • Figure Revenue and Market Share Analysis of Taejoon Pharm (South Korea)

    • Table Product and Service Introduction of Taejoon Pharm (South Korea)

    • Table Company Profile and Development Status of Lantheus (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus (US)

    • Figure Sales and Growth Rate Analysis of Lantheus (US)

    • Figure Revenue and Market Share Analysis of Lantheus (US)

    • Table Product and Service Introduction of Lantheus (US)

    • Table Company Profile and Development Status of Spago Nanomedicine (Sweden)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spago Nanomedicine (Sweden)

    • Figure Sales and Growth Rate Analysis of Spago Nanomedicine (Sweden)

    • Figure Revenue and Market Share Analysis of Spago Nanomedicine (Sweden)

    • Table Product and Service Introduction of Spago Nanomedicine (Sweden)

    • Table Company Profile and Development Status of JB Chemicals and Pharmaceuticals (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JB Chemicals and Pharmaceuticals (India)

    • Figure Sales and Growth Rate Analysis of JB Chemicals and Pharmaceuticals (India)

    • Figure Revenue and Market Share Analysis of JB Chemicals and Pharmaceuticals (India)

    • Table Product and Service Introduction of JB Chemicals and Pharmaceuticals (India)

    • Table Company Profile and Development Status of Magnus Health (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Magnus Health (India)

    • Figure Sales and Growth Rate Analysis of Magnus Health (India)

    • Figure Revenue and Market Share Analysis of Magnus Health (India)

    • Table Product and Service Introduction of Magnus Health (India)

    • Table Company Profile and Development Status of Guerbet (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guerbet (France)

    • Figure Sales and Growth Rate Analysis of Guerbet (France)

    • Figure Revenue and Market Share Analysis of Guerbet (France)

    • Table Product and Service Introduction of Guerbet (France)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.